These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 3378957)

  • 61. A multicenter international study on the activity of sulbactam/ampicillin, ampicillin, and cefoxitin against anaerobic bacteria and introduction of a new model of susceptibility testing in mixed infections.
    Heizmann WR; Heilmann F; Werner H
    Suppl Int J Gynecol Obstet; 1989; 2():7-12; discussion 47-8. PubMed ID: 2679683
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antimicrobial susceptibility testing of anaerobic bacteria.
    Rosenblatt JE
    Rev Infect Dis; 1984; 6 Suppl 1():S242-8. PubMed ID: 6372033
    [TBL] [Abstract][Full Text] [Related]  

  • 63. In vitro activities of cefminox against anaerobic bacteria compared with those of nine other compounds.
    Hoellman DB; Spangler SK; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1998 Mar; 42(3):495-501. PubMed ID: 9517922
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antimicrobial therapy of postpartum endomyometritis. I. Comparative susceptibility of mezlocillin and other antibiotics to genital anaerobic bacteria.
    Sorrell TC; Marshall JR; Chow AW
    Am J Obstet Gynecol; 1981 Oct; 141(3):242-5. PubMed ID: 6456667
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Multicentre survey of the in-vitro activity of seven antimicrobial agents, including ertapenem, against recently isolated Gram-negative anaerobic bacteria in Greece.
    Papaparaskevas J; Pantazatou A; Katsandri A; Legakis NJ; Avlamis A;
    Clin Microbiol Infect; 2005 Oct; 11(10):820-4. PubMed ID: 16153256
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In vitro activity of cefbuperazone compared with that of other new beta-lactam agents against anaerobic gram-negative bacilli and contribution of beta-lactamase to resistance.
    Del Bene VE; Carek PJ; Twitty JA; Burkey LJ
    Antimicrob Agents Chemother; 1985 May; 27(5):817-20. PubMed ID: 3874597
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Major methodology-dependent discordant susceptibility results for Bacteroides fragilis group isolates but not other anaerobes.
    Aldridge KE; Schiro DD
    Diagn Microbiol Infect Dis; 1994 Nov; 20(3):135-42. PubMed ID: 7874880
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In vitro sensitivity of anaerobic bacteria to fosfomycin.
    Altés Gutiérrez A; Rodríguez Noriega A
    Chemotherapy; 1977; 23 Suppl 1():51-7. PubMed ID: 583867
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [A diffusion method to find the antimicrobial sensitivity of Bacteroides fragilis. Comparative study with a plate dilution technic].
    de la Torre Misiego F; López Bartolome O; Betriu Cabecerán C; Rodríguez Avial C; Cogollos Agruña R
    Rev Clin Esp; 1984 Aug 15-31; 174(3-4):103-5. PubMed ID: 6515069
    [No Abstract]   [Full Text] [Related]  

  • 70. Evaluation of the in vitro activity of levornidazole, its metabolites and comparators against clinical anaerobic bacteria.
    Hu J; Zhang J; Wu S; Zhu D; Huang H; Chen Y; Yang Y; Zhang Y
    Int J Antimicrob Agents; 2014 Dec; 44(6):514-9. PubMed ID: 25301712
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clindamycin resistance in anaerobic bacteria.
    Tally FP; Cuchural GJ; Bieluch VM; Jacobus NV; Malamy MH
    Scand J Infect Dis Suppl; 1984; 43():34-43. PubMed ID: 6598519
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Bacteroides fragilis group: trends in resistance.
    Fille M; Mango M; Lechner M; Schaumann R
    Curr Microbiol; 2006 Feb; 52(2):153-7. PubMed ID: 16450067
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Emergence of antibiotic resistant strains of Bacteroides fragilis.
    Scher KS
    Surg Gynecol Obstet; 1988 Sep; 167(3):175-9. PubMed ID: 3413646
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The activity of cefotaxime and desacetylcefotaxime alone and in combination against anaerobes and staphylococci.
    Jones RN; Barry AL; Packer RR
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):37S-46S. PubMed ID: 6086217
    [TBL] [Abstract][Full Text] [Related]  

  • 75. In vitro activity against anaerobes of retapamulin, a new topical antibiotic for treatment of skin infections.
    Odou MF; Muller C; Calvet L; Dubreuil L
    J Antimicrob Chemother; 2007 Apr; 59(4):646-51. PubMed ID: 17350985
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Interaction between penicillin, clindamycin or metronidazole and gentamicin against species of clostridia and anaerobic and facultatively anaerobic gram-positive cocci.
    Brook I; Walker RI
    J Antimicrob Chemother; 1985 Jan; 15(1):31-7. PubMed ID: 3972757
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mechanisms of resistance and resistance transfer in anaerobic bacteria: factors influencing antimicrobial therapy.
    Tally FP; Cuchural GJ; Malamy MH
    Rev Infect Dis; 1984; 6 Suppl 1():S260-9. PubMed ID: 6326243
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Identification of anaerobic bacteria isolated from various clinical specimens and determination of antibiotic susceptibilities].
    Doğan M; Baysal B
    Mikrobiyol Bul; 2010 Apr; 44(2):211-9. PubMed ID: 20549955
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Susceptibility of strict anaerobic bacteria to antibiotics in France: a multicenter study].
    Grollier G; Mory F; Quentin C; Girard-Pipau F; Tigaud S; Sedallian A; Dubreuil L
    Pathol Biol (Paris); 1994 May; 42(5):498-504. PubMed ID: 7824321
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evaluation of the E-test for susceptibility testing of the Bacteroides fragilis group. Danish study group.
    Bremmelgaard A; Jansen JE; Justesen T; Gottschau A
    APMIS; 1994 Jun; 102(6):446-50. PubMed ID: 8068304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.